Lazarides Miltos K, Argyriou Christos, Koutsoumpelis Andreas, Georgakarakos Efstratios I, Georgiadis George S
1 Medical School, University of Cyprus, Nicosia, Cyprus.
2 Department of Vascular Surgery, Democritus University of Thrace, Alexandroupolis, Greece.
J Vasc Access. 2018 Sep;19(5):430-435. doi: 10.1177/1129729818762991. Epub 2018 Mar 18.
Thigh arteriovenous grafts are required in a number of patients with exhausted upper extremity veins and comprise 1%-5% of the total access procedures performed. Alternative autogenous lower extremity options are the rarely used sapheno-tibial arteriovenous fistulae, the saphenous vein transpositions, and the femoral vein transpositions. The latter have proven to be the most durable lower limb access procedures, with low infection rates and their primary patency rates ranged from 74% up to 87% at 2 years. Synthetic thigh grafts are suitable for patients who are not good candidates for any upper limb or any autogenous lower limb access and their secondary patency rates ranged from 54% up to 83% at 2 years. Thigh grafts often get infected and their average weighed infection rate in 920 such grafts included in eight large series was 22.9%. A literature search was performed to evaluate thigh grafts compared with alternative options using meta-analysis. Lower limb accesses were found superior compared to HeRO device regarding 1-year primary failure rate (odds ratio = 0.28, confidence interval = 0.09-0.88, p = 0.03) and additionally autogenous lower limb accesses were found superior compared to thigh grafts regarding the 1-year primary failure rate (odds ratio = 6.54, confidence interval = 2.29-18.72, p = 0.0005).
许多上肢静脉耗竭的患者需要进行股动静脉移植,其占所有血管通路手术的1%-5%。下肢自体血管的替代选择包括很少使用的隐-胫动静脉内瘘、大隐静脉转位术和股静脉转位术。事实证明,后者是最持久的下肢血管通路手术,感染率低,其2年的初始通畅率在74%至87%之间。人工合成股移植适用于不适合上肢或任何自体下肢血管通路的患者,其2年的二次通畅率在54%至83%之间。股移植经常发生感染,8个大型系列研究纳入的920例此类移植的平均加权感染率为22.9%。通过文献检索,采用荟萃分析评估股移植与其他替代方案。结果发现,下肢血管通路在1年初始失败率方面优于HeRO装置(优势比=0.28,置信区间=0.09-0.88,p=0.03),此外,自体下肢血管通路在1年初始失败率方面优于股移植(优势比=6.54,置信区间=2.29-18.72,p=0.0005)。